DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,034 filers reported holding DANAHER CORPORATION in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,385,482 | +731.4% | 9,615 | +789.5% | 0.16% | +933.3% |
| Q4 2022 | $286,919 | -31.5% | 1,081 | -34.6% | 0.02% | +25.0% |
| Q2 2022 | $419,000 | +95.8% | 1,652 | +126.9% | 0.01% | +100.0% |
| Q1 2022 | $214,000 | -16.7% | 728 | -6.7% | 0.01% | -14.3% |
| Q4 2021 | $257,000 | +7.5% | 780 | -54.9% | 0.01% | -56.2% |
| Q1 2020 | $239,000 | -37.9% | 1,730 | -31.0% | 0.02% | +6.7% |
| Q4 2019 | $385,000 | -12.7% | 2,508 | -17.8% | 0.02% | -25.0% |
| Q3 2019 | $441,000 | +406.9% | 3,050 | +263.5% | 0.02% | +233.3% |
| Q4 2018 | $87,000 | -65.2% | 839 | -63.6% | 0.01% | -60.0% |
| Q3 2018 | $250,000 | +71.2% | 2,305 | +55.7% | 0.02% | +66.7% |
| Q2 2018 | $146,000 | -59.6% | 1,480 | -59.9% | 0.01% | -65.4% |
| Q1 2018 | $361,000 | +37.3% | 3,690 | +18.2% | 0.03% | +4.0% |
| Q2 2017 | $263,000 | -46.7% | 3,122 | -45.8% | 0.02% | -46.8% |
| Q1 2017 | $493,000 | -48.4% | 5,764 | -53.0% | 0.05% | -59.1% |
| Q4 2016 | $955,000 | +31.4% | 12,266 | +32.3% | 0.12% | +51.3% |
| Q3 2016 | $727,000 | -63.1% | 9,270 | -52.5% | 0.08% | -72.5% |
| Q2 2016 | $1,971,000 | +646.6% | 19,517 | +601.8% | 0.28% | +645.9% |
| Q1 2016 | $264,000 | +3200.0% | 2,781 | +2990.0% | 0.04% | +3600.0% |
| Q4 2015 | $8,000 | -99.1% | 90 | -99.2% | 0.00% | -99.2% |
| Q3 2015 | $903,000 | +1541.8% | 10,600 | +1556.2% | 0.13% | +1537.5% |
| Q2 2015 | $55,000 | -48.1% | 640 | -48.8% | 0.01% | -46.7% |
| Q1 2015 | $106,000 | -68.8% | 1,250 | -68.5% | 0.02% | -70.0% |
| Q4 2014 | $340,000 | +330.4% | 3,971 | +297.1% | 0.05% | +400.0% |
| Q2 2014 | $79,000 | +777.8% | 1,000 | +733.3% | 0.01% | +900.0% |
| Q4 2013 | $9,000 | +50.0% | 120 | +50.0% | 0.00% | 0.0% |
| Q3 2013 | $6,000 | – | 80 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |